TDOC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TDOC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-13), Teladoc Health's share price is $11.95. Teladoc Health's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $-2.35. Hence, Teladoc Health's Price to Tangible Book Ratio of today is .
The historical rank and industry rank for Teladoc Health's Price-to-Tangible-Book or its related term are showing as below:
During the past 11 years, Teladoc Health's highest Price to Tangible Book Ratio was 313.25. The lowest was 3.95. And the median was 44.51.
A closely related ratio is called PB Ratio. As of today, Teladoc Health's share price is $11.95. Teladoc Health's Book Value per Sharefor the quarter that ended in Mar. 2024 was $13.52. Hence, Teladoc Health's P/B Ratio of today is 0.88.
The historical data trend for Teladoc Health's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teladoc Health Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Price-to-Tangible-Book | Get a 7-Day Free Trial | 143.36 | - | - | - | - |
Teladoc Health Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Price-to-Tangible-Book | Get a 7-Day Free Trial | - | - | - | - | - |
For the Health Information Services subindustry, Teladoc Health's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Teladoc Health's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Teladoc Health's Price-to-Tangible-Book falls into.
Teladoc Health's price-to-tangible-book ratio for today is calculated as:
Price to Tangible Book | = | Share Price | / | Tangible Book per Share (Q: Mar. 2024 ) |
= | 11.95 | / | -2.354 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Price to Tangible Book | = | Market Cap | / | Tangible Equity | ||||
= | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock | - | Intangible Assets) |
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Thank you for viewing the detailed overview of Teladoc Health's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Daniel Trencher | officer: SVP Corporate Strategy | 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
Vidya Raman-tangella | officer: Chief Medical Officer | 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
Karen L Daniel | director | 2801 80TH STREET, KENOSHA WI 53141 |
Jason N Gorevic | director, officer: President & CEO | |
Andrew Turitz | officer: SVP - Business Development | C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
Stephany Verstraete | officer: Chief Marketing Officer | C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
Adam C Vandervoort | officer: Chief Legal Officer, Secretary | 485 MADISON AVENUE, NEW YORK NY 10022 |
Mala Murthy | officer: Chief Financial Officer | C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
Richard J Napolitano | officer: Chief Accounting Officer | MSCI INC., 7 WORLD TRADE CENTER, 250 GREENWICH STREET, 49TH FLOOR, NEW YORK NY 10007 |
Arnnon Geshuri | officer: Chief Human Resources Officer | 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
Laizer Kornwasser | officer: PRESIDENT, ENTERPRISE GROWTH | 100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417 |
Michael Willem Waters | officer: CHIEF OPERATING OFFICER | 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
Jason Eric Evans | director | 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027 |
Claus Torp Jensen | officer: Chief Innovation Officer | 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
Sandra L Fenwick | director | C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577 |
From GuruFocus
By Marketwired • 08-10-2023
By sperokesalga sperokesalga • 04-12-2023
By GuruFocus Research • 12-29-2023
By Marketwired • 07-18-2023
By Stock market mentor Stock market mentor • 02-01-2023
By Stock market mentor Stock market mentor • 01-05-2023
By GuruFocus Research • 10-30-2023
By Marketwired • 07-10-2023
By sperokesalga sperokesalga • 03-25-2023
By Marketwired • 10-04-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.